A method for preparing hallow-cored luminescent mesoporous silica reservoirs
The present invention refers to light emitting hydroxyapatite nanoparticles having an ionic bond, a thin; silica precursors tetra ethyl [...] (TEOS) for said light emitting hydroxy [...] nano-particle emitting coated silica mesoporous coating step of manufacturing a hydroxyapatite; said mesoporous silica coated light emitting hydroxy of hydroxyapatite in which a portion of mesoporous silica a coating portion fourth step the hydroxyapatite is positioned between the circular discs in internal nuclear is removed by two step processes of characterized by including to, mesoporous silica light-emitting hollow relates to manufacturing method of the surface of the developing roll. Therapeutic diagnostic and nanoparticles that can be used for the application are viewed as up-and-coming player of wet liquid to flow down (Cho K, Wang X, Nie SM, Chen Z, Shin MD. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008 ; 14 : 1310-6. Kim J, Piao YZ, Hyeon t. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev 2009 ; 38: Chatterjee DK 372-90., Fong LS, Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev 2008 ; 60 : 1627-37.). Inorganic nanoparticles that a relatively low toxicity, and these properties to permit function and surface a fine regulating a well-controlled synthesis method is connected to the semiconductor layer.. Therefore, a wide range of a medicament inorganic nanoparticles for delivery of preparing hybridoma producing the anti-within biologically-compatible non-volatile memory elements is considered important material of wet liquid to flow down (Guo Y, Shi DL, Cho H, Dong ZY, Kulkarni A, Pauletti GM, et al. In vivo imaging and drug storage by quantumaodash.dashaoconjugated carbon nanotubes. Adv Funct Mater 2008 ; 18: You J 2489-97., Zhang GD, Li C. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. ACS Nano 2010 ; 4: Tang S 1033-41., Huang XQ, Chen XL, Zheng NF. Hollow mesoporous zirconia nanocapsules for drug delivery. Adv Funct Mater 2010 ; 20: Lin mm 2442-7., Kim HH, Kim H, Dobson J, Kim DK. Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy. Nanomedicine 2010 ; 5 : 109-33.). , The, drug delivery systems with greater precision and low doses better controlled method having the colouring substances in target tissue only drug interaction of delivery of drug targeting been design for. Silica nanoparticles (mesoporuous) mesoporous in particular drug delivery material candidate highest in appearance of wet liquid to flow down (Manzanoab M, Vallet-Regi m. New developments in ordered mesoporous materials for drug delivery. J Mater Chem 2010 ; 20 : 5593-604. Yang P, Gaib S, Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev 2012 ; 41 : 3679-98.). These ingestion of a large amount of drugs for large surface area and larger volume such as and outputs the second command, and specifically from molecules to be applicable to surface can easily adjust properties of of the clear unit is off (Li Z, Barnes JC, Bosoy A, Stoddart JF, Zink JI. Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev 2012 ; 41: Ariga K 2590-605., Vinu A, Yamauchi Y, Ji Q, Hill JP. Nanoarchitectonics for mesoporous materials. Bull Chem Soc Jpn 2012 ; 85: Coll C 1-32., Bernardos A, Martinez-Manez R, Sancenon F. Gated silica mesoporous supports for controlled release and signaling applications. Acc Chem Res 2013 ; 46 : 339-49. Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater 2012 ; 24 : 1504-34.). Furthermore, release of the drug porous structure and surface chemistry that is, controlled by can be. A subordinate storage capacity of drug molecules in an effort an increase and/or host specificity interconnected by targeting enhancing, pore volume reinforcement or a pore size of their pores as for optimizing the level of the of wet liquid to flow down a rectangle plate shape ([14] Chen Y, Chen HR, Zhang SJ, Chen F, Zhang LX, Zhang JM, et al. Multifunctional mesoporous nanoellipsoids for biological bimodal imaging and magnetically targeted delivery of anticancer drugs. Adv Funct Mater 2011 ; 21: Yang J 270-8., Lee J, Kang JY, Lee K, Suh JS, Yoon HG, et al. Hollow silica nanocontainers as drug delivery vehicles. Langmuir 2008 ; 24:Li LL 3417-21., Tang FQ, Liu HY, Liu TL, Hao NJ, Chen D, et al. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. ACS Nano 2010 ; 4 : 6874-82. Singh RK, Kim TH, Kim JJ, Lee EJ, Kim J, Knowles JC, et al. Mesoporous silica tubular nanocarriers for the delivery of therapeutic molecules. RSC Adv 2013 ; 3 : 8692-704.). Including mesoporous silica, another of nanoparticles an important characteristic is, for example, light emitting, photodynamic, electrical and electronic properties provide multi-functional such as its ability to deal with relates to ([18] Kim J, Lee JE, Lee J, Yu JH, Kim BC, An K, Shin CH, Park JG, et al. Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J Am Chem Soc 2006 ; 128 : 688-9. Chen H, Colvin DC, Qi B, Moore T, He J, Mefford OT, et al. Magnetic and optical properties of multifunctional coreshell radioluminescence nanoparticles. J Mater Chem 2012 ; 22 : 12802-9.). Mainly this therapeutic is used to target diagnosis system capabilities relates to. Organic dye and quantum dots (QDs) mainly because their more excellent luminous properties biological labeling and diagnosis been the applied (Burns A, Ow H, Wiesner U. Fluorescent coreshell silica nanoparticles: towards "Lab on a Particle" architectures for nanobiotechnology. Chem Soc Rev 2006 ; 35: Bruchez MJ 1028-42., Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science 1998 ; 281 : 2013-5.). However, said light-emitting organic pigment and that an is extinction or preferable composition to be rapidly degraded properties, quantum dots caused from Cd2+ and Pb2+ such as severe cytotoxic is heavy, . a limitation on biological applications ([22] Wang F, Liu X. Recent advances in the chemistry of lanthanide-doped up conversion nanocrystals. Chem Soc Rev 2009 ; 38: Bouziques C 976-89., Gacoin T, Alexandrou A. Biological applications of rare-earth based nanoparticles. ACS Nano 2011 ; 5 : 8488-505.). Therefore, while maintaining developing an appropriate video Image biologically stabilised for variety of materials is critical to develop a source objects' traces to. The inventor is in the light emitting target Image as well as well-controlled drug containing/emission ability and multifunctional braced that owns a novel mesoporous biocatalyst (MS)-based nanocomposites he made efforts toward to be development delivery system. Furthermore, light emitting hydroxyapatite (LHA: luminescent hydroxyapatite) he made efforts toward at the same. Hydroxyapatite biological materials which bone and as including teeth and material generally of tissue rigid, biocompatible thus been found it. ([24] Matsumoto T, Okazaki M, Inoue M, Yamaguchi S, Kusunose T, Toyonaga T, et al. Hydroxyapatite particles as a controlled release carrier of protein. Biomaterials 2004 ; 25: Rauschmann MA 3807-12., Wichelhaus TA, Stirnal V, Dingeldein E, Zichner L, Schnettler R, et al. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 2005 ; 26 : 2677-84.). In particular, said hydroxy of hydroxyapatite in which a portion of crystal forms have under AA low water solubility leading to a disadvantage of presence depends on the or impurities, self-activated light emitting and emit (Zhang C, Li C, Huang S, Hou Z, Cheng Z, Yang P, et al. Self-activated luminescent and mesoporous strontium hydroxyapatite nanorods for drug delivery. Biomaterials 2010 ; 31: Green WH 3374-83., Le KP, Grey J, Au TT, Sailor MJ. White phosphors from a silicate-carboxylate sol-gel precursor that lack metal activator ions. Science 1997 ; 276: Jakob AM 1826-8., Schmedake TA. A novel approach to monodisperse, luminescent silica spheres. Chem Mater 2006 ; 18: Angelov S 3173-5., Stoyanova R, Dafinova R, Kabasanov K. Luminescence and EPR studies on strontium carbonate obtained by thermal decomposition of strontium oxalate. J Phys Chem Solids 1986 ; 47:He Q 409-12., Shi J, Cui X, Wei C, Zhang L, Wu W, et al. Synthesis of oxygen-deficient luminescent mesoporous silicananoparticles for synchronous drug delivery and imaging. Chem Commun 2011 ; 47 : 7947-9.). Light emitting hydroxyapatite its excellent optical properties and a biocompatible emitting won up-and-coming player as the free surfaces-excited. The present inventor the light hydroxyapatite on a layer of a mesoporous biocatalyst emitting hydroxy apatite-mesoporous biocatalyst for a shell structure-nuclear (LHA-MS) obtained. Light emitting hydroxy apatite-mesoporous biocatalyst (LHA-MS) outside of a drug porous structure to controlling the release and drug containing. Furthermore, the present inventor are nuclear area light-emitting hydroxyapatite the via hole is formed in the additional drug containing a structure obtain an enough (hollow-core MS (hMS)) used for forming it has been confirmed. Such a structure said silica other carrying the drug compared based system an ability to advantageously interesting has been to enhance significantly, hollow structure (hMS) is in addition light emitting hydroxyapatite light-emitting properties observed that it is possible for integrity the n bit parallel data inputted, as a result-based derivative, novel light emitting mesoporous silica support (L-hMS) have been prepared. Used in access copy mold until now a hollow mesoporous silica of the physical shape the reported bar left ([31] Hu J, Chen M, Fang X, Wu l. Fabrication and application of inorganic hollow spheres. Chem Soc Rev 2011 ; 40: Lou XWD 5472-91., Archer LA, Yang Z. Hollow micro-/ nanostructures: synthesis and applications. Adv Mater 2008 ; 20 : 3987-4019.). The light emitting the present invention such as a hollow strip to form mesoporous silica was reported bar. Furthermore, the present inventor are of emitting light in drug delivery system in a cell destined to mesoporous silica support (L-hMS) for applying the represented by chemical doxorubicin (DOX) and light emitting ability supported doxorubicin using mesoporous silica support from release profile doxorubicin used as the material for intracellular delivery system the biological effects of the a result, it is possible to the present invention, is completed. The present purpose of the invention emitting hydroxyapatite nanoparticles having an ionic bond, a thin; silica precursors tetra ethyl [...] (TEOS) for said light emitting hydroxy [...] nano-particle emitting coated silica mesoporous coating step of manufacturing a hydroxyapatite; said mesoporous silica coated light emitting hydroxy of hydroxyapatite in which a portion of mesoporous silica a coating portion fourth step the hydroxyapatite is positioned between the circular discs in internal nuclear is removed by two step processes of to characterized by including, hollow manufacturing method of light-emitting mesoporous silica support by a rope. provides. Another object of the present invention is said method in turn may be prepared by a hollow light emitting mesoporous silica support electrode 104 is provided under the. Said end of the, the present invention refers to light emitting hydroxyapatite nanoparticles having an ionic bond, a thin; silica precursors tetra ethyl [...] (TEOS) for said light emitting hydroxy [...] nano-particle emitting coated silica mesoporous coating step of manufacturing a hydroxyapatite; said mesoporous silica coated light emitting hydroxy of hydroxyapatite in which a portion of mesoporous silica a coating portion fourth step the hydroxyapatite is positioned between the circular discs in internal nuclear is removed by two step processes of characterized by including to, mesoporous light-emitting hollow provides manufacturing method of silica support. In the present invention, said light emitting hydroxyapatite nanoparticles preparation of the known method is produced by may be, one in the embodiment of the present invention in hexa thread tree methyl ammonium bromide and the mixed solution of calcium nitrate hemihydrate and tetrahydrofuran ammonium hydrate mixed solution of trisodium citrate phosphate and disintegrant by mixing emitted by precipitation reactor solution supersaturated with a hydroxyapatite nanoparticles shown. One embodiment of the present invention and/or at least two different light emitting produced hydroxyapatite a carbon-related impurities is observed light emitting phenomenon due to the presence of pure is formed among the light emitting hydroxyapatite (LHA: luminescence hydroxyapatite) main light emitting the CO2- is ion radical. In the present invention, a nano particle collector hydroxyapatite light emitting said 10 nm to 100 nm is, one in the embodiment of the present invention senses a rotation velocity of the disk on in 3% zinc nitrate hexahydrate hexa thread tree methyl ammonium bromide added to the mixed solution of calcium nitrate hemihydrate and tetrahydrofuran by light emitting hydroxyapatite particle size reduced μm as some tenths. One embodiment of the present invention light method for producing hydroxyapatite along the axis relative to the hexa thread tree methyl ammonium bromide pH of the mixed solution of calcium nitrate hemihydrate and tetrahydrofuran for 9 to 10 ammonium hydroxide to regulate the. may be added solution. In the present invention, light emitting coated silica mesoporous said step of manufacturing a hydroxyapatite a hexatriene thread tree methyl ammonium bromide (CTAB) deionized water and ammonium hydroxide including a hydroxyapatite that emit light at a given time added to the solution in an ultrasonic-page facsimile after mixing and preparation of a solution of mixed solution produced said tetramethyl ethyl [...] addition to prevent agglomeration for step of applying a ultrasonic to be used as a screw driver may comprise an. Furthermore, in the present invention, said tetra ethyl [...] 50 micro l to 400 micro l it is preferable that the added. Tetra ethyl [...] used less than 50 micro l silica coating caused by using a complete is inserted, tetra ethyl [...] 400 micro l used beyond the longer silica coating is formed larger in thickness do not go preferably formed. In addition said shell thickness of concentration of agent composed of ethyl [...] (TEOS) (30 mg LHA l micro TEOS 50 per 400 micro l to in), controlled by various can be. In the present invention, the mesoporous silica coating the partially hydrolyzed TEOS molecules nano LHA heterogeneous of lead ball and separates the lead on the surface of the particles for forming nuclei in which, this carried in particulate nano LHA car layer the deposition process on stable, silanol groups in order to form alkaline conditions (pH 9 to 10 here) in the. can be done by concentrate reagents. Silica precursors tetra [...][...] hydroxy (TEOS) for emitting said mesoporous silica coating nano-particle coated light emitting hydroxyapatite one in the embodiment of the present invention for fabricating a thread tree methyl ammonium bromide (CTAB) of hexa in ammonium hydroxide in deionized water and added to solution hydroxyapatite that emit light at a given time the n bit parallel data inputted acoustic reactor (Sonoreactor, Ulsso Hitech) under ultrasonic-page facsimile high using mixed. Tetra ethyl [...] (50, 100, 200, 300 and 400 micro l) various the n bit parallel data inputted added to mixture an amount, prevent agglomeration for was to give supersonic waves to be used as a screw driver. 1200 rpm then distributed the mixture. The n bit parallel data inputted ultrasonic treatment after the fluid is thereby said hexa thread tree methyl ammonium bromide (CTAB) and the deionized water has acidity below absolute ethanol for removing completely cleaning the n bit parallel data inputted during night under vacuum and drying the mesoporous silica coated light emitting hydroxyapatite (LHA@MS) a are obtained. Tetra ethyl [...] the mesoporous silica having increased amounts by lowering a clear level 62 nm to 6 nm in thickness also somewhat straight line increase can be verify. In the present invention, the hydroxyapatite inside said internal nuclear is removed by two step processes of said mesoporous silica coated light emitting hydroxyapatite a deionized water and is dispersed in the ammonium nitrate the addition of. can be done by. In one in the embodiment of the present invention light-emitting hollow mesoporous silica support in order to achieve an, said mesoporous silica coated light emitting hydroxyapatite in nuclear area light-emitting hydroxyapatite etching a the dissolved the connection means. Mesoporous silica coated light emitting hydroxyapatite a deionized water was nonperiodic dispersing after HCl solution and mixed. Agglomeration prevention and and to give supersonic waves to the mixture said order to mix was against of recalibration. Said mixture then ammonium, on the nitrate dissolved in deionized water was filtered. Said solution ethanol and the n bit parallel data inputted cleaning and ultrasonic deionized water, then light-emitting hollow mesoporous silica support to obtain the drying under vacuum. As a result light-emitting hollow mesoporous silica support can be obtain. Said manufacturing method in the present invention a hollow in turn may be prepared by an inner as nuclei emitting mesoporous silica support despite removal of is hydroxyapatite light emitting emitting still representative of the feature extension of.. This phenomenon is light emitting hydroxy [...] CO2- mesoporous silica ion radical can be since the TSL. Furthermore, the present invention refers to said in turn may be prepared by method of light-emitting is hollow provides mesoporous silica support. Said mesoporous silica for delivery of the drug carrier can be used uses, of the present invention a anti-cancer drugs in one experiment using the drug doxorubicin (DOX) of enamine ability has been confirmed. In particular, a gradual transition in drug molecules of waste shell mesoporous silica by diffusion of water and nuclear feet walking by equipping been supported in the free space, then in vivo delivery system are formed at the suitable. In particular, anti-cancer using ruby shoes toxin tissue the treatment cardiotoxic death and the Image through a general efficaciously non controlled release due to high of a medicament lack correctness of and drug dose. is related. Mesoporous silica of the present invention light-emitting hollow carrier including ruby shoes toxin by using controlled preparation of drug molecules release and sustained, along with the ability, characterised in that the flanges provide containing and has its ability to generate new vessels. Said toxin within cells of a nanoparticles carrying ruby shoes drug insertion of the surface of the developing roll self-light-emitting ability in situ since the a lane indicator is good to be imaging has the treatment of the solid type. In one experiment of the present invention manufacturing method of the present invention by emitting a hollow substrated mesoporous silica support porous and physical main including optical activity showed assay of electrochemical properties. Furthermore, of a substance such as with ruby shoes toxin containing ability and hollow light emitting mesoporous silica support release profile of the ECU stops the operation in vitro intracellular delivery system biological effectiveness of a candidate identified. Of the present invention manufacturing method in turn may be prepared by a hollow light emitting mesoporous silica support (L-hMS) ruby shoes effect contains a anti-cancer drugs toxin over order reception and consisting of pH-dependent manner can be of the high-speed. Furthermore, of the present invention light-emitting hollow mesoporous silica carrier transmitted into cells very effectively is directed through subsequent 4,4 '-methyl bix a doxorubicin (DOX) by effectively cell death, in tumor cells under has come about,. Furthermore, self-active fluorescent properties resistance and excellent medical products having protection function for the cellular and the treatment of disease of repairing a rheologically and and video therapeutic in the arrangement is expected to be. Also Figure 1 shows a hollow of the present invention light-emitting mesoporous silica support a manufacturing process of a indicating a mimetic is. Figure 2 the present invention of the surface of the developing roll drug produced by means of. to present images TEM. (A) LHA (b) MS50 (c) MS100 (d) MS200 (e) MS400 and (f) L-hMS, various (g) made of TEOS concentration and a mesoporous silica coated light emitting hydroxyapatite (LHA@MS) nano of TEOS concentration conditions according to silica shell. to apply a first fluid. FTIR spectrum of the sample carrier drug (b) Figure 3 (a) XRD pattern (c) a peak EDS stores each sequence of the plurality of blades, presenting a composition atoms (P vs and Ca LHA inside. LHA@MS Ca inside, Si vs and P. Inside L-hMS Si) (d) shell thickness of thickening in the negative according to the gradual in a any significant increase of nanoparticles measured at pH 7.0 ζ-potential concerns a.. A then analyzed by Figure 4 BET method exhibiting mesopores having 0.5-10 nm. : (a) drug delivery (b) the isothermal line absorption/desorption nitrogen gas of the sample specific surface area (c) specific pore volume, and a (d) each drug mesoporous pore size of the surface of the developing roll. Spectral power fluorescence emission of the surface of the developing roll drug Figure 5 of the present invention. : (a) (b) of the present invention typical fluorescence emission spectrum of the surface of the developing roll drug fluorescence emission spectrum of the surface of the developing roll drug (c) of the present invention fluorescent Image EPR spectrum of the surface of the developing roll drug (d) of the present invention. Figure 6 shows a representative of the present invention also as in the embodiment using carrier drug L-hMS and LHA@MS200 DOX drug containing and emission is shown values for a : (a) initial DOX of agricultural according to DOX (b) graph indicating a loading amount of initial drug two different time 48 of the surface of the developing roll and have an emission DOX (c) 300 of graph L-hMS DOX from a long period of time of not until time and have an emission of graph. Figure 7 shows a also (a) DOX dosage-dependent manner and concerns a prolonged periods of ischemia according to HeLa, time (b) 4 1 micro gml-1 DOX-supported L-hMS or 1 micro gml-1 DOX solution of cells grown on result of scanning microscope dot laser confocal HeLa concerns a.. DOX also Figure 8 shows a a-supported L-hMS HeLa by chemical-mechanical polishing of cell death cell. concerns a method for saving of : (a) DOX dosage-dependent manner annexin of cells according to HeLa V/PI dyeing representative point plot (b) DOX dosage-dependent manner according to caspase-3 FACS indicative of expression of analysis. Hereinafter, to assist in the understanding of the present invention a preferred embodiment. thereby, the cold air flows. However, the present invention of the following embodiment relate to more easily in order to understand the CDK provided, and/or at least two different embodiment of the present invention content is limited not. A a starting material and compounds used in the reagents into its original reagent yarn Aldrich, without any solvent purely, the third to eo the drying or high purification. In the embodiment 1: light emitting mesoporous silica support manufacturing In the embodiment 1-1. Light emitting hydroxyapatite for preparing nano particles of Light emitting hydroxyapatite a lead B A solution and by mixing solution of solution supersaturated with a and were produced by precipitation reactor. Solution 0.6 g ammonium bromide (CTAB) hexa thread tree methyl the A 1.3743 g and a hemihydrate its senses a rotation velocity of the disk on 60 ml 3% calcium nitrate and zinc nitrate hexahydrate was is produced by mixing a. Said zinc ions emitting hydroxyapatite particle size μm as some tenths the additional reducing. Ammonium hydroxide solution (28%) a pH of 9 to 10 a small amount (- 3 ml) to regulate the A added to the solution. B solution dissolved in 15 ml deionized water, ammonium hydrate 1.7646 g phosphate and disintegrant 0.4752 g of trisodium citrate mixing a have been prepared by. 10 minutes after mixing of, solution B A been introduced into the solution of sodium/trisodium citrate ratio A. 1:1 molar ratio calcium nitrate were selected from. 60 minutes after stirred additional, said stainless steel solution, and move the bottle made political autoclave and, after packing 24 reacted in 185 °C time. After cooled to room temperature [...] auto, light emitting hydroxyapatite a 8000 rpm in centrifugal separation was precipitate into outside solution. Furthermore, precipitated hydroxyapatite nanoparticles which washes the de-ionized water and ethanol, then dried in air time 24 80 °C the hydroxyapatite nanoparticles are obtained. In the embodiment 1-2. Mesoporous silica coated light emitting hydroxyapatite for manufacturing Light emitting hydroxyapatite template on porous silica coating silica precursors tetra ethyl [...] (TEOS) and a layer forming the light emitting hydroxyapatite obtained by mixing. Tetra ethyl [...] before additional, 200 ml of ethanol to 30 mg hydroxyapatite light-emitting synthesized at the input packet doesn't have any error in the bath 30 minutes to give supersonic waves cd1a. all illuminated hydroxyapatite particles well defined shape a silica coating produce is disposed at visitor is checked through a stirring 500rpm. Furthermore, ammonium bromide (CTAB) 5 g thread tree methyl of hexa in ammonium hydroxide 8 ml 22 ml deionized water and added to solution hydroxyapatite that emit light at a given time the n bit parallel data inputted 700W and 20kHz in 30 minutes (Sonoreactor, Ulsso Hitech) acoustic reactor using high-page facsimile ultrasonic under mixed 30 minutes. Tetra ethyl [...] (50, 100, 200, 300 and 400 micro l) various the n bit parallel data inputted added to mixture an amount, prevent agglomeration for 2 was to give supersonic waves additionally time. Then mixture during night in said well-dispersed 1200 rpm and a mesoporous silica coated light emitting hydroxyapatite for obtaining the distributed. The n bit parallel data inputted ultrasonic treatment after the fluid is thereby said hexa thread tree methyl ammonium bromide (CTAB) and the deionized water has acidity below absolute ethanol for removing completely cleaning the n bit parallel data inputted during night under vacuum and drying the mesoporous silica coated light emitting hydroxyapatite (LHA@MS) a are obtained. In the embodiment 1-3. Hollow mesoporous silica support manufacturing light-emitting Light-emitting hollow mesoporous silica support in order to achieve an, that is obtained from said in the embodiment 1-2 mesoporous silica coated light emitting hydroxyapatite in nuclear area light-emitting hydroxyapatite etching a the dissolved the connection means. L micro 200 in particular said tetra ethyl [...] produced with the aid of side and a mesoporous silica coated light emitting hydroxyapatite (LHA@MS200) was network device that has selected it as a representative example. Furthermore, 0.15 g of silica coated light emitting hydroxyapatite (LHA@MS200) a dispersed to synchronize the then 30 ml deionized water 20 ml 1 N HCl solution and mixed. Said mixture agglomeration prevention and and ultrasonic time 2" end-to-end order to mix 1200 rpm stirring section. Said mixture during night in 60 °C then dissolved in 40 ml deionized water was filtered in ammonium nitrate 20 mg. Said nanoparticles solution ethanol and the n bit parallel data inputted cleaning and ultrasonic deionized water, then light-emitting hollow mesoporous silica support to obtain the drying during night under vacuum. As a result light-emitting hollow mesoporous silica carriers are obtained (also 1). Experiment 1 e.g.: light emitting mesoporous silica support properties of analysis 1-1 e.g. experiment. Experiment method Emitting a hollow produced mesoporous silica support nanoparticles for measuring the crystal structure of, in 40 mA and 40 kV, cu Kα the ink chamber is pressed by the copy (k = 1.5418 A) (Rigaku) diffraction (XRD)-ray diffraction analyses-X using the lower substrate in a plane form. The scanning 2 θ = 10° to 60° of translucent gas, 2°min-1 scanning speed and characterised in that it is made with step size was 0.02 °. Conversion enemy external spectroscopy the functional group and sample (FTIR; Varian 640-IR) for characterizing a chemical reaction of the been used. Respect to each spectral, 400-1800 cm-1 frequency range of the RF input filter 20 scan method using KBr pellets, been recording diffraction film. Nanoparticles and are sized and shaped for a transmission electron microscope it was determined that using (TEM; JEOL-7100). The ethanolamine the sample to the TEM on is by dispersion of metal nanoparticle and method for carbon-coated copper geometrical adaptation blended-droplets on the suspension. Particulate nano the thickness of the shell formed silica to TEM Image (> 50 nanoparticles) it was determined that the randomly selects a in. Said sample of atoms composition energy-dispersion spectrometer (EDS; Bruker) was then analyzed by. Zeta (ζ) potential of the sample said end time zeta element (ZEN3600; Malvern) it was determined that using. Said ζ-potential de-ionized water, which, in 25 °C has been determined electrode is formed on 3. Specific surface area, pore volume, and a pore size of 77 K Quadrasorb SI in automated surface area and pore size spectrometer (2SI-MP-9 Quanta-chrome) using nitrogen gas absorption/desorption isotherm have been determined by. Surge under vacuum prior to analysis, 100 °C to exterior gas of time of degassing temperature, and 4, and removed the gas sample. Said nanoparticles size, as measured by a dynamic light scattering measuring aperture (DLS) on the basis of particle size spectrometer (Zetasizer Nano ZS, Malvern Instruments, UK) was subject to analysis by. Said properties light-emitting sample nanoparticles Jasco FP-6500 spectrogram-light emitting system has been determined by the photoluminescent (PL). In addition said Image of the sample, using deionized water for rinsing the reference as the solution the UV trans the first base this it pushes was by using a (Vilber Lourmat). Said nanoparticles of electronic paramagnetic resonance (EPR) 9.4 GHz in a modulation magnetic field properties of X-band frequency of 100 kHz is in a non-operating (m) (model JES-FA200) apparatus for interfacing with JEOL was used to characterized using. 1-2 e.g. experiment. Result Also, as shown to 1, said nuclear template used are provided to the light emitting hydroxyapatite (LHA) using the TEOS brush-gel by mesoporous silica (LHA@MS) to coated. The thickness of the shell said concentration of TEOS (30 mg LHA l micro TEOS 50 per 400 micro l to in), controlled by various been. Prior to adding a TEOS, brush mixtures said LHA solution, coating process for distribution as well as the simultaneous sonication. More particularly, the partially hydrolyzed TEOS LHA molecules adsorbed onto the surface of the nanoparticles for forming nuclei in heterogeneous the n bit parallel data inputted corresponding advertisement based on the shown list, this carried in particulate nano LHA car layer the deposition process on stable, silanol groups in order to form alkaline conditions (pH 9 to 10 here) under been accompanied concentrate reagents. Furthermore, said nuclear LHA is hollow and a mesoporous silica nanoparticles are removable as to form particles with been, in addition this (L-hMS) it put out Natta emission. Drug molecules by diffusion of water a gradual transition in mesoporous silica of waste shell, in which compressor compartment a compressor and bin feet walking by equipping been supported on, then a delivery system adequate is formed to allow the plating solution. Drug carrier Figure 2 form of TEM as shown to been investigation by. LHA has nuclear template (core template, also 2a) been used as 30 nm to 40 nm × 10 nm length having the length of width (average 37 nm × 11 nm) revealed a form-shape rod. Also different 2b-e made of TEOS concentration and a mesoporous silica coated light emitting hydroxyapatite showed Image TEM of nano (LHA@MS). Said silica the skin and constant mesoporous morphology hydroxyapatite light emitting to have the. is cleaned by using RF plasma. For example the thickness of the shell said concentration makes the production conditions of such as TEOS (also 2g) can be unit. L micro 50 TEOS 400 micro l amount in the thickness of the therefore the shell by of increasing to 62 nm to 7 nm have been increased to. Thickness and TEOS amount (R2 = 0.99) there has been a relationship straight between. This TEOS the thickness of the of the shells for regulating the concentration can easily adjust by meaning that the.. Shell portion ingestion of drug molecules in an an important role, shell thickness for accurate adjustment of action of nano play an important part in a responsible. The shape acid LHA nuclear area is for gradually removing hollow as a result corresponding advertisement based on the shown light-emitting mesoporous silica support obtained forms (also 2f). The elimination of waste shell silica said mesoporous structure added up is not the inner space. Such nuclear in shell carrier and a mesoporous hollow and pores in both acceptable volume have been shown to ability containing drug a gain. Said shell portion as a barrier against the diffusion of drug molecules is believed to scavenge behavior is, for example, shell thickness of said layer increases by lowering a clear level drug molecules supported on a hollow space while drug channel to mesopores having 0.5-10 nm the delay release of the molecules. The thickness of the TEOS TEM a husk of the signal substrate and the amount has been determined from an Image of a (also 2g). The thickness of the silica shell by lowering a clear level having increased amounts of TEOS, TEOS 400 in a 50 micro l according to of various micro l 62 nm to 6 nm in somewhat straight line have been increased. In the same method, said (LHA@MS) hydroxyapatite light emitting coated silica nano of 161 nm × 135 nm to 49 nm × 23 nm in size have been increased coincide with each other. Said hydrodynamic, and a particle diameter of between in addition DLS of the measurements was dee by method. Tetra ethyl [...] produced with the aid of side l micro 200 and a mesoporous silica coated light emitting hydroxyapatite (LHA@MS200) and hollow and a mesoporous silica support (L-hMS) into a representative sample to be, the third to eo. Each analysis respect to said DLS L-hMS and LHA@ MS-200 102 nm and revealed a particle size of 120 nm. From Image TEM LHA@MS200 (93 nm × 67 nm) considering the size of, increases somewhat size measured said DLS a the long purchases the passenger, in solution of nanoparticles was reflect a hydrodynamical effect. The nanoparticles generally increased such small disperse well is assigned a somewhat serious without aggregating means a. During effect on the prevention of diseases by said in the form of phase and crystal structure, designated the analyzed using XRD. Light emitting hydroxyapatite are crystalline hydroxyapatite-istics that are typical for revealed a peak (also 3a). Mesoporous silica shell is formed, dominant one in 2θ = 23° wide peak, this typical silica relates an amorphous phase was observed. Said associated silica of a peak strength shell as the thickness of said layer increases was increases according to an. Hydroxyapatite and silica expected relates to a heat sink that any peak also LHA@MS and unbreakable is of the sample did not observed even in. Light emitting hydroxyapatite nucleus upon removal (L-hMS sample), only the width of said surface being larger amorphous silica peak revealed that. Such discovery light emitting hydroxyapatite nuclear complete removal of a reliable removal of a to the rear side of the main. Chemical structures of said drug carrier which is then analyzed by a FTIR spectrometry (also 3b) was. The nuclear hydroxyapatite light emitting said 1096, 1020, 960, 600 and 565 cm-1 been representing band characteristic in, this PO43- ion in vibration and a particular feature of P-O layer coding means, relates. Additional band 1577-1 and 1375 cm-1 a massage cream, an essence, observed in, this CO2- been corresponding to. Said OH- for stretching vibrations 630 cm-1 out. In a sample LHA@MS, silica-related band is in addition shown. Si-O-Si (1220 cm-1 and 1095 cm-1 symmetrical in a stretching, and 801 cm-1 a stretching asymmetrically), Si-OH (954 cm-1 symmetrical in a stretching) and Si-O (465 cm-1 in bending) the primary band power is fed, strength according to thickening silica thickness have been increased. Respect to L-hMS, revealed that band is-related silica only. Said FTIR was coincident with the XRD result. Interesting advantageously, said 1300 cm-1 to 1600 cm-1 the likelihood that all samples band in a range (LHA, in particular L-hMS and LHA@MS) been found in, all drug generally certification the chemical bonded to the outer layer of the surface of the developing roll. This carbon-related layer coding means, relates with the presence of impurities. Substantially, pure LHA main light emitting element CO2- radical ion and, in addition this allocated to the band. Critical, as they, hydroxyapatite light emitting in addition this is hollow is removed and a mesoporous silica present in a sample, the elimination hydroxyapatite the light-the hollow after a radical, in which compressor compartment a compressor. retention of ions. EDS analysis of the surface of the developing roll said each nanoparticle containing at it is found out that additionally delivery system (also 3c). Ca and P is the laser beam is transmitted through an hydroxyapatite light emitting it is apparent that while, additional Si LHA@MS the picks and appear to signal main in in a sample, in reservoir nano L-hMS only one Si peak (non-P and Ca) was there is only. These base compositions result crystalline hydroxyapatite as nuclei surely complete removal of the, FTIR and in accord. A delivery nano said ζ-potential are separated the for measuring the properties of the surface charge in distilled water having dispersed the (also 3d). Voice ζ-potential all revealed that in a sample. In particular, said LHA of ζ-potential mesoporous silica shell application of negatively charged more to fixing member, have been increased with an increase in shell thickness and (18.1 mV-LHA LHA@MS400-26 mV in). Ζ-potential (- 21.8 mV) has said L-hMS of silica compositions LHA@MS400, that reflects the effect (- 22.4 mV) and the value of a corresponding the each other. The crystal structure of LHA OH- and PO34- ion for there are charge of of the voice LHA while the is capable of having, a water soluble shell mesoporous silica is easy to to hydrolysis under medium, enriched in the voice Si-OH on the surface form groups. Said silica shell surface area presentation properties, pore volume, and a pore-size observed these including mesopores having 0.5-10 nm structure depth greater by been analyzed in, loaded with the drug molecules for capabilities that are important in in determining the presence of functions, as a parameter. First, said drug delivery for the isothermal line absorption/desorption nitrogen gas of the sample was used to plot (also 4a). All LHA@MS indicating area loop hysteresis narrow sample that of traditional components formed out of showed type the isothermal line IV. A given pressure area in mesoporous silica shell thickness is by lowering a clear level adsorbed to the volume have been increased. Hollow and a mesoporous silica revealed a volume as the adsorption highest. In particular, a curve the isothermal line said 0.45 < p/p0 < 0.9 in the relative pressure area been representing loop hysteresis, this characterized by a of nano-structre networked cavity, revealed that similarly even in a different location (Tang JT, Liu J, Wang PY, Zhong H, Yang QH. Evolution fromhollow nanospheres to highly ordered FDU-12 induced by inorganic salts under weak acidic conditions. Microporous Mesoporous Mater 2010 ; 127: Fan J and 119-25 ., Yu CZ, Gao F, Lei J, Tian BZ, Wang LM, et al. Cubic mesoporous silica with large controllable entrance sizes and advanced adsorption properties. Angew Chem Int Ed 2003 ; 42 : 3146-50.). On the basis of to the isothermal line, said specific surface area it was determined that volume and pores. Surface of a sample area is shell thickness MS 110 m2 g-1 in 510 m2 g-1 have been increased in accordance with increased (also 4b). And in addition have been increased a pore volume said (0.15 cm3 g-1 from 0.450.818 cm3 g-1 also in 4c). Furthermore, said hollow pore volume and surface area and a mesoporous silica (each 1012 cm3 g-1 and 0.818 cm3 g-1) substantially increased has been observed on. These findings of the shells mesopores having 0.5-10 nm along further molecules drug nuclear hollow storing an amount of. (also 4d). LHA@MS in in a sample, said mesoporous -3.6 nm was applying a vibration to the pores. While, hollow mesoporous silica, average mesoporous -4.3 nm was a pore size. A nuclear small changes in the of this size in relates to the elimination of LHA from may be proposed. While, their pore size measuring used for hollow model BJH an internal space from accurately mesoporous pores identification may not be. However, typical pore size distribution curve based on (also 4d internal), in (- 4.3 nm) average value this sharp peak pore size narrow WIPO purchases the passenger, said pore broadening effect been exciting the more rational. L-hMS inside Bin space extended capabilities in very as well as mesoporous structure optimum condition required in the production of a silica hydroxyapatite layer and reduces the light emitting efficiency of shell identify the, light emitting of the nanoparticulate then it was determined that properties. According to bar reported prior to, hydroxy citric acid sol-gel for the production of hydroxyapatite in which a portion of when used as chelating, R-C-COO- (Cit3-) the Ca composite chelating rate site so as to form an hydroxyapatite on the surface is detected, whether particles exist was gradually. Additional to space, said Cit3- the R-C and CO2,- to can be, in some CO2,- radical the hydroxyapatite grid or between tissue luminescent centers as a result and a transversal position of formation of of was. Wide light-emitting range herein HA fluorescence emission and the typical bandwiths and 5a also spectrum showed to. 300 nm to 400 nm in the wider spectral capacity, 340 nm been reported to have a 2001, corresponding 427 nm revealed that in the emission spectrum. Said drug carrier 5b to all of the sample showed Figure band emission spectrum. 466 nm and 427 nm band two center in a spectrum mesoporous silica and hollow hydroxyapatite light emitting shell and a mesoporous silica carriers including all the nano carriers have revealed that similarly material layer to a current. Said LHA@MS nuclear to which it is spectral emission PL of the sample originating from LHA can be understood because and, present mesoporous silica of waste shell-repellant effect, that reflects the emission band in strength low the rear side of the main unit. However, said hollow mesoporous silica in a sample emission spectrum corresponding in LHA nuclei are due to the somewhat surprising exhibits results. This light-emitting LHA and plays a major role in the behavior believe that the a CO2,- even after the elimination radicals remaining in an empty space still since are believed to be.. The elimination during CO2,- radical may by using a some portion of the incoming television programs, whereas, and thought, the remaining most, only LHA@MS200 (pre-manufacture a hollow sample) from that of the mesoporous silica hollow compared to light emitting in that may have been be revealed that a reduction in. FTIR results in the region of previous, 1300 to 1600 cm-1 LHA band common peripheral, to the likelihood that all samples including a L-hMS and LHA@MS been viewed, in addition this function, soft touch and pleasant wearing CO2,- supporting the presence of radical. Said observed from measurement of the PL the first base this it pushes trans UV results in Image that is caused by equal to the 100,000. will match (also 5c). In addition said L-hMS of somewhat stable properties PL, PL of nanoparticles ambiguous since the strength under a condition the tarnish after storage can be validly been it. To determine the light emitting mechanism, drug carrier respect to EPR sample performed for all the sample (also 5d). G = 1.9805 and g = 2.1177 typically sample said LHA (here g is the Lande g elements) EPR in precursor and CaO precursor band, sincerely LHA nano-particle in paramagnetic defects was which implies that the there is. EPR signal P5+, Ca2+ or O2- caused by cannot be this (these ions al less single electron in) in some it ladles, the jade thread lighting knife or carbon dioxide radical ion (CO2-) the size of the defect-related radical such as of hope appeared. from. Similarly, sample of other nanostructures signal EPR (L-hMS and LHA@MS) are shown in, the signal strengths while accepted when MS shell thickness is increased and reduced in addition drug carrier when extended diagonally inside false report (L-hMS) signal strengths are is reduced. Nano all measuring PL results said EPR effective delivery is that paramagnetic defects, mainly this CO2- radical ions such as ions that the agreed to that certification. Experiment 2 e.g.: light emitting mesoporous silica support of study and release containing doxorubicin 2-1 e.g. experiment. Experiment method 120 micro lml-1 substantially exfoliated vermiculite inventory at concentrations of doxorubicin (DOX) in order in the mounted in PBS pH 7.4 for. 483 nm of absorption in solution inventory using spectrophotometer UV-vis (20, 30, 40, 60, 80, 100 and 120 micro lml-1) in order of optical strength standard by estimating an obtained curve. DOX containing for the test, 1 mg of nanoparticles sample (L-hMS and LHA@MS) for 5 minutes each DOX been distribute the ultrasonic solution 4 was lower and this adamantane is stored at water tank 37 °C time. Drug loading amount for quantifying the, said nanoparticles 10,000rpm in the n bit parallel data inputted centrifugal separator 5 minutes, the supernatant UV-vis spectrophotometer (A483 nm) analyzed using was collecting for. DOX from the sample delivery nano provided in order to measure the release profile, initial DOX concentration 120 micro lml-1 that are manufactured in a nanofiber delivery said DOX-supported (L-hMS and LHA@MS) the first voice portion out of an. For measuring the rediolarele emission DOX, the other 2 mg sample each pH value (7.4 and 5.5) dispersed 2 ml PBS produced by good in 37 °C then the n bit parallel data inputted. In other time point (maximum 2 main), amount of a medicament emitted improves. 10,000 rpm 5 minutes it was determined that in centrifugal after separation nanoparticle-drug complex, said supernatant and transmits, UV-vis then it was determined that using spectrophotometer (A483 nm). Said been ventilation in testing each media. 2-2 e.g. experiment. Result (Molecules), or therapeutic substance, and for and delivery support materials is medicament development provided in order to measure the capabilities of the surface of the developing roll, doxorubicin (DOX) anti-cancer drugs is were selected. Toxin ruby shoes has a pKa of 8.3, this in pH 7.4 of charges to be blood, also without additional functionality to carrier a drug which exhibits negative charge may be. Furthermore, toxin ruby shoessmall element and mesopores having 0.5-10 nm has a hollow even channel (3 nm to 4 nm) can be inserted into. Studies have two representative containing said DOX drug carrier using performed for all the (and hollow LHA@MS200 L-hMS). Micro g g 20 a supported said DOX in various micro 120 by DOX concentration in a given drug carrier concentration (1 mg) been recorded in. LHA@MS200 in the case of, the amount carried with said DOX using gradually increases according to an having increased amounts of DOX been, micro 60 sample LHA@MS200 g/ml-1 to a maximum 30 micro g of enamine been is recorded. In the case of L-hMS, having increased amounts in addition DOX the amount containing said DOX by lowering a clear level straight line maximum loadings pattern the most as high as the level of g micro 70 80 micro g/ml-1 have been increased up. Drug containing ability of the surface of the developing roll and various significantly thus, for example, L-hMS (micro g 70) supported on the amount of DOX LHA@MS200 (30 micro g) supported on been doubled in comparison to what is. Clearly the results indicate that DOX molecules of enamine in exhibits effect of nuclear hollow. Mesoporous silica DOX oppositely surface and the small dimensions of the X ray from leaking from the charge since the, easily insertion channel mesopores having 0.5-10 nm is higher than the first voltage through spatial channels hollow even permits penetration. Supported DOX different pH value was the emitted succession to PBS. A normal physiological conditions while its pH 7.4, acidic pH 5.3 outside cell of tumor cells exhibits of the tissue. L-hMS or said LHA@MS200 48 original emission pattern and minimize the interaction from one of two first time (also 6b) showed. Said emission pattern and minimize the interaction for example subsequently to augment the sustained exists due to the discharged fast initial a specific channel of performance data memorized 10 clearly two-step and have an emission which show behavior. Initial fast release mainly at the outer surface a DOX molecules or mesopores having 0.5-10 nm arising from portion outermost channel-volatile memory elements is considered to, here a water molecules in DOX molecules to decompose rapidly for permeation and to the, thus, these can be discharged therefrom.. Acidic pH with the fact that it has a DOX molecules associated with enhanced protonated, is thus occur in the this portion easy and rapid that the, important exhibits results of pH-dependent release. While, second, mesopores having 0.5-10 nm step profile inside Bin channel (in the case of LHA@MS200) of internal and/or of an empty space of the internal (in the case of L-hMS) that the presence of additional release of DOX is believed to reflect and, mainly by diffusion mechanism is dominant. LHA@MS200 L-hMS than from DOX from more higher initial emission (until time 10) in a solvent to form a slurry in the L-hMS more DOX is speculative to since amount of. Relation to effect and pH, pH-dependent discharge pattern indicative of DOX has two kinds of drug delivery in acidic conditions than when neutral conditions when faster than it has been discovered that the emitting. Such pH-sensitive against as possible due to soluble of DOX DOX molecules NH2 since the protonated a strong group in ionic and/or acidic environment can be increased. Furthermore, pH 7.4 than L-hMS drug carrier faster release rate exhibiting in pH 5.3, sensitive to pH.. 10 time L-hMS DOX emission results from about 38%, about 42% and 48 24 time cd1a. time about 53%, substantially this said washing liquid are expelled in a pH 7.4 was doubled frequency multiplied signal 108 in percent (10 time about 19%, 24 time about 23%, about time 48 and 34%). PH-dependent DOX emission behavior after confirming the receivable channel to, we additionally over an extended period of time in hollow release profile of DOX drug carrier from sensors (also 6c). As certification, entire emission pattern and minimize the interaction consists of in two stages, for example, initial fast release is continues until time maximum step 10, after emission ranges are until end is held (until time about 300), two pH gradually in a curvilinear has a pattern. Advantageously interesting, originally a pH 7.4 and 5.3 pH-dependent difference between the differential without any narrow a color purity maintaining even second step was shown. As certification, mesopores having 0.5-10 nm profile section that is retained after for changing transmission speed. resulting from diffusion DOX. Although water molecules (proton in acidic pH) is DOX molecules for decomposing and ion exchange (between DOX and a mesoporous silica surface) in freely dispersed in the polymer can be gripped to, DOX at five LAN time and time it would take for the diffusion process over. and thus results in gas emission are maintained. Furthermore, these two-stage behavior DOX he made efforts toward release of mechanism to be found. O 10 time difference model (Mt/M∞ = K0 t) applied step straight primary until verified for the coarse programming process while, the equation Ritger-Peppasempirical been applied to a later step, this Mt/M∞ = Ktn law (Patel KD, El-Fiqi A, Lee HY, Singh RK, Kim DA, Lee HH, et al. Chitosannanobioactive glass electerophoretic coatings with bone regenerative and drug delivering potential. J Mater Chem 2012 ; 22 (47): 24945-56) along implying, here Mt and M∞ t and infinity (∞) time time in America petroleum Institute of drug release means, K0 K and the respective average respect to which constant release rate, the structural and geometrical carrier drug includes properties, n the emission indices and, exhibits drug release mechanism. On the basis of the scene model said, been represented as graph an external in addition, in actual data this average have shown that good fitting. Table 2 mechanical drug release has a parameter determining equation (K0, K and n) acquisition of abstract value. corresponds. In the first step, higher in implying a rate constants for said acidic conditions, acidic pH DOX molecules associated with protonated more higher is presented and therefore longer. emission disintegration and fast. Furthermore, secondary step speed in constants suffers higher subsequently to augment the in acidic conditions, in curve behavior reflect the faster initial rise. Power obtained at the second step, a cd1a. 0.46 (pH 7.4) and 0.32 (pH 5.3) constants, such emitted step higher mechanical is regulated to by emission signature lies. Furthermore, acidic medium somewhat in low power constants since depletion separated from each drug molecules is resource determined to be. On the basis of study and release containing DOX, mesoporous silica hollow said drug carrier for drug delivery non-volatile memory elements is considered as an efficient transmission.. Hollow space in a solvent to form a slurry positive and number of DOX molecules of a controlled-release mechanism 12 by the same time as a long-thereby exceed the guiding a transmission period is consonant. Silica nanoparticles prior to a drug delivery for the purpose of continuously studied of color cathode, nano nine Roseau rapid drug release and any abrupt of drugs from depletion a common been reporting to problems of [18, 46, 47]. Some these limitations (ethylene glycol) on the nanoparticles including formation of complex in various phase been caused by, is inserted into a pore this speed of drug release through slow the rear side of the main unit. Excitation nuclear is hollow in this case, the production of the structure of (chemical and geometric) by regulation of the drug release profile certification a possibility. However, here DOX respect to said certification is the same as that the effect of the mesopores having 0.5-10 nm and a mesoporous hollow structure (pore size, and a porous tissue-paper also) and surface function vaporizer for the application to drugs specific and must be conditioned and to appropriately monitor since class of drugs bipolar the not must be applied. Experiment 3 e.g.: light emitting mesoporous silica support cytotoxicity of experiment 3-1 e.g. experiment. Experiment method Manufacturing drug delivery in vitro of cytological the toxicity human cervical cancer cell line forcibly emitting cells (HeLa cells, American Type Culture Collection, Rockville) it was determined that using. Cells (Gibco) erythromycin [...]oh serum Streptomyces-penicillin 1% and 10% minimum essentially in culture medium (a-MEM; Gibco) 5% CO2 of 37 °C in the gas phase, which has the in. Said media formal bow on New Year's Day times or two week been replaced with, said cells through the saturation. The MTS for analysis, per well cells HeLa 104 96-well to a density of cells the n bit parallel data inputted the division plate the contacted time 24. Then the contact said 24 in a culture medium which is time various L-hMS dosage amount, DOX, or DOX was filtered L-hMS a-supported. Each processing after, said cells 4 in the darkness 37 °C l micro α-MEM 100 time l micro 20 solution and MTS (CellTiter 96 Aqueous One Solution; Promega) was the culture, a mixed solution prepared. MTS processing end, OD value in said 490 nm was read using iMark microplate reader (BioRad). Cell survival degree beyond an experiment using a computer to the control group value of OD groups for monitoring the percentage of value it was determined that on the basis. 3-2 e.g. experiment. Result Forcibly as tumor cell representative emitting cell line (HeLa cell line) cells using DOX in survival is-supported mesoporous silica drug carrier sensors. For group measured under the different kind of representative positive, effective dosage range generally unknown a general DOX emitting forcibly in a variable dose was filtered to DOX time. 24 (HeLa cells) cells treated with prolonged periods of ischemia HeLa degree gradually reduces the DOX dosage-dependent manner according to the n bit parallel data inputted, by finding the effect of cytotoxicity of DOX showed (also 7a). Next, DOX-supported by using a L-hMS drug carrier. In this case, the amount containing said DOX representative group (0,0.1,0.5, 1, 5, 10, 20, 40 and 60 micro gml-1) DOX flowed in is related to the amount of in accord. As a result, 0 each concentration corresponding of a reservoir of nano said L-hMS, 1.43, 7.15, 14.28, 71.4, 142.8, 285.6, micro 856.8 and 571.2 gml-1 has been determined as. Forcibly supported DOX emitting cells in treated L-hMS, areas at the surface between the plural gradually purpose: a method cell survival in addition part, this constant dose-dependent manner and the immediate DOX for viewed pattern and that is similar to that of a reference temperature step. This effect is L-hMS partake of from DOX or from drug delivery to identify whether or not, only L-hMS [...] to DOX (DOX-free) L-hMS a-supported on the same concentration was filtered. In this case, said cell survival was well-preserved degree. 285.6 micro gml-1 drug L-hMS of ion conductor of the surface of the developing roll, said emitting forcibly activity such that a rate of prolonged periods of ischemia having biocompatible L-hMS to was 90.4%. Such drug L-hMS cell survival excellent degree of the surface of the developing roll intracellular intake step for delivery of the medication treatment of the which can very effectively ameliorate acting. it is believed that. The results indicate that results in an a-supported in addition DOX L-hMS cytotoxic effect in drug carrier in a solvent to form a slurry, isn't it coming from DOX molecules L-hMS drug carrier coming from was means that it will not. More specifically, initial 24 within a period time, DOX from carrier drug L-hMS to an event that both a man is only the addition is not emitted in the, a-supported DOX drug carrier L-hMS a cell survival level caused by DOX only by the treatment of only, resulting lower turbine. Furthermore, the results indicate that of naked (naked) DOX and a drug carrier by other cell between DOX are formed in a resource determined to be because mechanism intake is. A-supported L-hMS said DOX drug carrier in viable cells includes mechanism intake, when a light enters cells than (naked) DOX of naked this copyright 2000. Based on the results of such as said, said L-hMS a potentially anticancer drug carrier, includes in particular DOX for and delivering the targeting cancer cells, since the sensitive pH anticancer drug delivery and enhances the potency of the a conveying as potentially can be used. Experiment 4 e.g.: doxorubicin cell HeLa a light emitting-supported mesoporous silica support to Image 4-1 e.g. experiment. Experiment method 4 L-hMS time, DOX or DOX-supported L-hMS treated with a 6-well culture plate each well 105 forcibly a frequency divides the cells emitting cells 4% and cutting device 30 minutes the aldehyde solution for controlling piezoelectric vibration. Cold PBS (4 °C) said fixed cells then being washed with the located slide glass then the n bit parallel data inputted. Said optical Image observing the Zeiss LSM 510 laser-scanning confocal microscope (Zeiss) human power by operating all systems by the n bit parallel data inputted. The a viewing end and an output end of a nucleus cells 40,6-diaryl diphenyl-Indol-2- roh midi (DAPI; Invitrogen, USA) was no stain. 4-2 e.g. experiment. Result A L-hMS said DOX-supported cells of sensors then intake. 1 micro g of DOX HeLa cells 4 or acid by treating the concentration of DOX-supported L-hMS a time corresponding to the n bit parallel data inputted processed, DOX cell supported L-hMS HeLa the position of the confocal dot laser scanning microscope (also 7b) been found by. Said red fluorescent signal portion exhibits blue said DOX only the signal resulting from nuclear-dyeable DAPI.. Said DOX of red fluorescent signal cytochrome HeLa or in plasma (near signal blue) in the nucleus of the cell (which coincide generally with the signal blue) can be observed. 4 cells in treated (naked) DOX of naked time, most of a diffusion signal red revealed that in cytoplasm in a pattern. Similarly, a L-hMS to DOX-supported during processing time 4, similar red signal is clearly revealed that in cells. In particular, also more resistant a red signal is L-hMS since the aggregation of DOX molecules in drug carrier is soldered by lead was to provide a two-dimensional. Therefore, by processing of the time only 4 the DOX-supported L-hMS nano of a reservoir of a fast intake it became clear that in the vola results. Furthermore, several cytoplasm of nano L-hMS signal red diffused from the side wall face of which can be released from the reservoir by DOX molecules been described. PH-sensitive DOX been emission in a range of some molecules physiologically acceptable salts and physiologically functional derivatives a slightly acidic cytoplasm as tumor cells which been localized in a region which does. DOX based on delivery profile (also 6 to as shown), initial hours in a solvent to form a slurry in DOX was about 10% - 20% is released. DOX contribute-L-hMS which are influenced by processing cell survival (also 7a) when said result, significant effect of ingredients within a period time, 24 becomes the first a DOX molecules resulting from anti-platelet and is released the free surfaces is expected to. Originally identified in pH 5.3 DOX within a period time, 24 is approximately 50% release profile from being released to the amount of enamine exhibit, such can be biological confirms. Although this encourages based on environment living cells can directly inferring although we cannot, DOX concentration significantly similar in a range, the damping material exhibits the biological result, intracellular domain is expected to emission in the free surfaces. Supported DOX has continues discharged, in which high intracellular fraction L-hMS in is held from the system, is adding water, raw milk, long-term capable. DOX and without dosage repeated and can deliver the drug to L-hMS drug carrier is that of the delivery system the acknowledgement message is one of.. Confocal fluorescence microscopy Image and cell survival pathways result L-hMS DOX drug carrier a-supported inner surface and quickly, a high content is released at said DOX molecules, cytoplasm in a restraint mainly revealed a result. Experiment 5 e.g.: cells (FITC)-annexin V extinction cell extinction[...] Prophy and fluefor iridium iodide(PI) double dyeing 5-1 e.g. experiment. Experiment method The DOX oh neck city -FITC double PI and V (Annexin V) a-supported thereby preventing necrosis cells is derived from an L-hMS verifies L-hMS time been used to. 24, a-supported DOX or DOX L-hMS emitting forcibly treated with cold and harvesting cells was then being washed with PBS. Said cleaning cells are annexin-FITC been by using a V Apoptosis Detection Kit (BD Pharmingen). The abstract, said cells 1×106 cells ml-1 in 1 ml of 1 × concentration of the floating in buffer coupled. Next, annexin V FITC l micro 5 PI and 5 micro l of a cell suspensions of (1×105 cells) 100 micro l the added to. After the beat soft, said cells 15 minutes at room temperature in the dark area good. Therefore, a 1×400 of buffer coupled micro l FACS Calibur flow cytometer (BD Biosciences) before analyzed using added to each tube. Each sample 10,000 cell is in the data that has obtained the analyzed using CellQuest Pro software (BD Biosciences). 5-2 e.g. experiment. Result Additionally (flow cytometry) geometry flow cytometer by using a-supported DOX drug carrier cell-intake properties L-hMS sensors. First, cells of a-supported said DOX L-hMS DOX step intake derived from a-supported cells of DOX L-hMS signal by estimating an oximetry flow cytometer been electrified quantitative (flow cytometry). L-hMS contribute thereby preventing necrosis a cell to be induced by the DOX for measuring the, treated cells a FITC-Annexin V and been dyeing dual-to PI, then was which is then analyzed by oximetry flow cytometer (flow cytometry). Cell membrane outside and externalization of (PS), that has a phosphatidyl serine into a cell death original indication steel. Therefore, Annexin V, from each other by an PS 2.10 with having affinity for cell death the-binding protein as a marker effective can be used. PI, non-specific or necrosis the drug is an intrusive DNA can enter the damaged cell but, viable cells or same cell death is U-turn indicating by on a membrane of an cells. Also, as shown to 8a, untreated population or a garnish HeLa cells treated L-hMS (w/o DOX) substantially cells didn't detected in cell death. However, cell death DOX group and treated with DOX a-supported significantly L-hMS been derived, for each has been about 19.6% and 57.4% level. Advantageously interesting, excellent apoptosis is DOX-only treatment on behalf of the DOX-supported from processing induced at a L-hMS of. Presentation of other, only in the group treated with DOX which appear as cell death is disclosed purchases the passenger minimum ratio of 19.6%, while in group a-supported L-hMS DOX, and set off a maximum 57.4% cell death. Non-cell death and non-volatile memory elements is considered-necrosis fraction cells, except cell death, and was killing by cause. In this regard, cell apoptosis HeLa cells treated with DOX DOX mechanism a-supported L-hMS same of cells treated with non-volatile memory elements is considered differently than non.: this DOX is transferred by the system containing drug L-hMS when further cell death is off. Experiment 6 e.g.: - 3 (caspase-3) cas fastener analysis of expression 6-1 e.g. experiment. Experiment method 3 cas fastener (active) FITC dyeing kit (BD Pharmingen) a-supported L-hMS the DOX is derived from an been used to verifies thereby preventing necrosis cells. L-hMS, DOX or DOX L-hMS treated with a-supported forcibly 24 time emitting cells is then harvesting the culture. Said cooling cells collected washed with PBS then the n bit parallel data inputted BD Cytofix/CytopermTM 30 minutes in ice is set up to come in solution. Fixing cells are cleaning burn one of the at least two buffer BD Perm/WashTM then the n bit parallel data inputted into dark 30 minutes, at room temperature in addition to antigen FITC-Caspase 3 BD Perm/WashTM the floating re buffer. Then cells dyeing said BD Perm/WashTM FACSCalibur flow cytometer washing buffer was analyzed using the n bit parallel data inputted. In each sample 10,000 obtained for the cells in said data was analyzed using CellQuest Pro software. 6-2 e.g. experiment. Result Cell death to identify behavior, additional expression caspase-3 of cells sensors area. Caspase-3 the same activated during cell death major protease and, similarly to the other kind of group caspase, cell death and inflammation in a is responsible for an important role. Also, as shown to 8b, substantially non-processing group and forcibly processing L-hMS (w/o DOX) (HeLa cells) in a dee caspase-3-emitting cells not positive cells. The HeLa cells-treated said DOX caspase-3 about positive cells revealed a 7.1%. However, contribute-L-hMS caspase-3 in DOX-processing HeLa cells have been increased significantly to about 58.6% positive cells. Caspase-3 expression such that the ratio of these results since the DOX-propagating L-hMS of DOX can be greater than when been indicative of the activity of cell death, this FACS analysis and in accord. DOX only addresses the processing of computers and indirectly with the DOX L-hMS of delivery drug delivery through the associated with apoptosis cell specifically a mechanism is it is apparent that the was is not decided yet. For casing pipe, and is a non to petty (endosomes) and a mesoporous surface structure of silica nanoparticles on silicic acid, having a highly HeLa as well as with the ability of including cell lines, cancer cells very into the efficient intracellular intake process cell death in a cell destined to distribution and DOX molecules fate destined signal a is responsible for an important role. The present invention relates to a method for preparing a hallow-cored luminescent mesoporous silica support. The method comprises the following steps: preparing luminescent hydroxyapatite nanoparticles; manufacturing luminescent hydroxyapatite coated with mesoporous silica by coating silica precursor tetraethyl ortho silicate (TEOS) on the luminescent hydroxyapatite nanoparticles; removing an inner nucleus by dissolving hydroxyapatite inside the luminescent hydroxyapatite coated with mesoporous silica, while leaving only a part coated with the mesoporous silica. A hallow-cored mesoporous silica support (L-hMS) prepared by the method of the present invention can effectively support an anti-cancer drug doxorubicin and induce the emission of the drug in a pH-dependent manner over weeks. In addition, it is found that hallow-cored mesoporous silica support according to the present invention is very effectively penetrated into cells, and meronecrosis effectively occurs in tumor cells by doxorubicin (DOX) transmitted thereby. Moreover, it is expected that the mesoporous silica support can be usefully used in repairing of cells and treatment of diseases in terms of treatment and medical imaging due to having magnetic-active fluorescent properties and superior biological stability. Light emitting hydroxyapatite nanoparticles having an ionic bond, a thin; silica precursors tetra ethyl [...] (TEOS) for said light emitting hydroxy [...] nano-particle emitting coated silica mesoporous coating step of manufacturing a hydroxyapatite; and said mesoporous silica coated light emitting hydroxyapatite a and is dispersed in deionized water, by the addition of ammonium nitrate the mesoporous silica a coating portion fourth step the hydroxyapatite is positioned between the circular discs in internal nuclear is removed by two step processes of the, hollow light-emitting mesoporous silica support is wound CO2- radical ions characterized by a the light emitting, hollow manufacturing method of light-emitting mesoporous silica support. According to Claim 1, hexa nanoparticles hydroxyapatite light emitting said thread tree methyl ammonium bromide and the mixed solution of calcium nitrate hemihydrate and tetrahydrofuran ammonium hydrate mixed solution of trisodium citrate phosphate and disintegrant by mixing of solution supersaturated with a to which in turn may be prepared by precipitation reactor characterized by, hollow manufacturing method of light-emitting mesoporous silica support. According to Claim 1, said light emitting hydroxyapatite nano particle collector characterized by a 10 nm to 100 nm provided that the, hollow manufacturing method of light-emitting mesoporous silica support. According to Claim 1, said mesoporous silica coated light emitting hydroxyapatite step of manufacturing a a a hexatriene thread tree methyl ammonium bromide (CTAB) deionized water and ammonium hydroxide including hydroxyapatite that emit light at a given time added to the solution in an ultrasonic-page facsimile after mixing and preparation of a solution of mixed solution produced said tetramethyl ethyl [...] addition to prevent agglomeration for step of applying a ultrasonic to be used as a screw driver to characterized by including, hollow manufacturing method of light-emitting mesoporous silica support. According to Claim 1, said tetra ethyl [...] l micro 400 to l micro 50 is further characterized by, hollow manufacturing method of light-emitting mesoporous silica support. Deleted Deleted Is hollow in turn may be prepared by any one of Claim 1 to Claim 5 method light-emitting mesoporous silica support. According to Claim 8, said mesoporous silica support for delivery of the drug doxorubicin toxin applications characterized by be used for light-emitting hollow mesoporous silica support.